| Tuan Trinh, DO | |
|
1401 W Jefferson Blvd, Dallas, TX 75208-5326 | |
| (214) 941-9200 | |
| (214) 494-1926 |
| Full Name | Tuan Trinh |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 1401 W Jefferson Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033244553 | NPI | - | NPPES |
| I06370 | Other | ECFMG |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L3507 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellmed Medical Group Pa | 4880657386 | 693 |
News Archive
QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.
The intersection of health care, politics and policy is a controversial one. A new book of lively essays takes on all of today's hot health topics: alternative medicine, swine flu, health care reform, screening mammograms, taxes to decrease soda consumption, gun control and many more.
› Verified 7 days ago
| Entity Name | Kingsley Medical Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497876288 PECOS PAC ID: 8426941899 Enrollment ID: O20040209000109 |
News Archive
QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.
The intersection of health care, politics and policy is a controversial one. A new book of lively essays takes on all of today's hot health topics: alternative medicine, swine flu, health care reform, screening mammograms, taxes to decrease soda consumption, gun control and many more.
› Verified 7 days ago
| Entity Name | Bruce E Wardle Do Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386765162 PECOS PAC ID: 5799769477 Enrollment ID: O20040618000127 |
News Archive
QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.
The intersection of health care, politics and policy is a controversial one. A new book of lively essays takes on all of today's hot health topics: alternative medicine, swine flu, health care reform, screening mammograms, taxes to decrease soda consumption, gun control and many more.
› Verified 7 days ago
| Entity Name | Wellmed Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437156486 PECOS PAC ID: 4880657386 Enrollment ID: O20041105000519 |
News Archive
QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.
The intersection of health care, politics and policy is a controversial one. A new book of lively essays takes on all of today's hot health topics: alternative medicine, swine flu, health care reform, screening mammograms, taxes to decrease soda consumption, gun control and many more.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tuan Trinh, DO 1401 W Jefferson Blvd, Dallas, TX 75208-5326 Ph: (214) 941-9200 | Tuan Trinh, DO 1401 W Jefferson Blvd, Dallas, TX 75208-5326 Ph: (214) 941-9200 |
News Archive
QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.
The intersection of health care, politics and policy is a controversial one. A new book of lively essays takes on all of today's hot health topics: alternative medicine, swine flu, health care reform, screening mammograms, taxes to decrease soda consumption, gun control and many more.
› Verified 7 days ago
Dr. Juan F Quiroz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4811a Columbia Ave, Dallas, TX 75226 Phone: 214-823-5590 Fax: 214-823-6638 | |
Dr. Michelle Dobbs, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6333 E Mockingbird Ln, Suite 126, Dallas, TX 75214 Phone: 214-826-6005 | |
Howard J Huntzinger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9250 Amberton Pkwy, Dallas, TX 75243 Phone: 682-236-3656 | |
Robert J Dimeff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8081 Walnut Hill Ln, Dallas, TX 75231 Phone: 214-750-1207 Fax: 214-739-5029 | |
Pardeep K Shori, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7012 La Vista Dr, Dallas, TX 75214 Phone: 817-564-5761 | |
Mary Elizabeth Wilcox Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 Fairmount St, Dallas, TX 75201 Phone: 214-742-9310 | |
Elizabeth Chapek, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Phone: 214-341-8742 |